MX2014000129A - Combinaciones de farmacos y su usos en el tratamiento de una condicion de tos. - Google Patents
Combinaciones de farmacos y su usos en el tratamiento de una condicion de tos.Info
- Publication number
- MX2014000129A MX2014000129A MX2014000129A MX2014000129A MX2014000129A MX 2014000129 A MX2014000129 A MX 2014000129A MX 2014000129 A MX2014000129 A MX 2014000129A MX 2014000129 A MX2014000129 A MX 2014000129A MX 2014000129 A MX2014000129 A MX 2014000129A
- Authority
- MX
- Mexico
- Prior art keywords
- treating
- drug combinations
- coughing condition
- coughing
- condition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
- A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/02—Ammonia; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
Abstract
La presente invención se refiere a composiciones que incluye una pluralidad de compuestos terapéuticos que tienen actividad antitusiva y a sus métodos y usos para tratar una condición de tos con tales composiciones.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1111485.7A GB201111485D0 (en) | 2011-07-05 | 2011-07-05 | Drug composition and its use in therapy |
PCT/GB2012/050816 WO2013004999A1 (en) | 2011-07-05 | 2012-04-13 | Drug combinations and uses in treating a coughing condition |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2014000129A true MX2014000129A (es) | 2014-05-28 |
Family
ID=44512137
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014000129A MX2014000129A (es) | 2011-07-05 | 2012-04-13 | Combinaciones de farmacos y su usos en el tratamiento de una condicion de tos. |
Country Status (12)
Country | Link |
---|---|
EP (2) | EP3251665A1 (es) |
JP (2) | JP2014518252A (es) |
KR (1) | KR101676454B1 (es) |
CN (1) | CN103648488A (es) |
AU (2) | AU2012280019B2 (es) |
BR (1) | BR112014000159A2 (es) |
CA (1) | CA2840793A1 (es) |
GB (1) | GB201111485D0 (es) |
MX (1) | MX2014000129A (es) |
RU (2) | RU2016101054A (es) |
WO (1) | WO2013004999A1 (es) |
ZA (1) | ZA201400010B (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10016437B2 (en) | 2009-06-16 | 2018-07-10 | Infirst Healthcare Limited | Drug combinations and uses in treating a coughing condition |
GB201014391D0 (en) * | 2010-08-27 | 2010-10-13 | Biocopea Ltd | Drug composition and its use in therapy |
GB0910375D0 (en) | 2009-06-16 | 2009-07-29 | Biocopea Ltd | Drug composition and its use in therapy |
GB201111485D0 (en) * | 2011-07-05 | 2011-08-17 | Biocopea Ltd | Drug composition and its use in therapy |
US9308211B2 (en) | 2009-06-16 | 2016-04-12 | Infirst Healthcare Limited | Drug combinations and uses in treating a coughing condition |
US9314465B2 (en) | 2009-06-16 | 2016-04-19 | Infirst Healthcare Limited | Drug combinations and uses in treating a coughing condition |
US9757529B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
US9757395B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
CN105473133A (zh) | 2013-04-30 | 2016-04-06 | 欧缇托匹克公司 | 干粉制剂及使用方法 |
CA2960622A1 (en) * | 2014-09-08 | 2016-03-17 | Gotham Biopharmaceuticals, Inc. | Methods of treating pulmonary sarcoidosis |
CN104436176A (zh) * | 2014-11-17 | 2015-03-25 | 华东理工大学 | 一种基于上呼吸道感染及肺炎用的新型生物抗菌喷雾剂 |
US10786456B2 (en) | 2017-09-22 | 2020-09-29 | Otitopic Inc. | Inhaled aspirin and magnesium to treat inflammation |
KR20230040375A (ko) | 2017-09-22 | 2023-03-22 | 오티토픽 인코퍼레이티드 | 스테아르산마그네슘을 갖는 건조 분말 조성물 |
GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
CN109793823A (zh) * | 2017-11-17 | 2019-05-24 | 中国科学院大连化学物理研究所 | 一种外用止咳平喘软膏剂及其制备方法 |
WO2020023486A1 (en) * | 2018-07-23 | 2020-01-30 | Trevi Therapeutics, Inc. | Treatment of chronic cough, breathlessness and dyspnea |
AU2020257625A1 (en) | 2019-04-17 | 2021-11-04 | Compass Pathfinder Limited | Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin |
US20240122934A1 (en) * | 2019-10-16 | 2024-04-18 | University Of South Florida | Compositions and methods of treatment for inhibiting capillary tube regression |
US20230346761A1 (en) * | 2019-12-31 | 2023-11-02 | The Trustees Of Indiana University | Repurposing fda-approved drugs as a novel cancer therapeutic avenue through inhibition of prmt5 |
US11628165B1 (en) * | 2020-03-25 | 2023-04-18 | Helen Feng | Method of boosting immune system against viral infection |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4756911A (en) | 1986-04-16 | 1988-07-12 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
US5378475A (en) | 1991-02-21 | 1995-01-03 | University Of Kentucky Research Foundation | Sustained release drug delivery devices |
US5869079A (en) | 1995-06-02 | 1999-02-09 | Oculex Pharmaceuticals, Inc. | Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
US20020009478A1 (en) * | 1998-08-24 | 2002-01-24 | Douglas Joseph Dobrozsi | Oral liquid mucoadhesive compositions |
JP2002363072A (ja) * | 2001-04-03 | 2002-12-18 | Taisho Pharmaceut Co Ltd | 鎮咳用組成物 |
JP2003081821A (ja) * | 2001-09-12 | 2003-03-19 | Taisho Pharmaceut Co Ltd | 医薬組成物 |
JP4377564B2 (ja) * | 2002-05-02 | 2009-12-02 | ロート製薬株式会社 | 内服用組成物 |
US6979689B2 (en) * | 2002-12-20 | 2005-12-27 | Pediamed Pharmaceuticals, Inc. | Compositions and methods for treating upper respiratory congestion |
US20050152967A1 (en) * | 2003-03-28 | 2005-07-14 | Pfab, Lp | Dynamic variable release |
AU2005209201B2 (en) | 2004-01-20 | 2010-06-03 | Allergan, Inc. | Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid |
US7799336B2 (en) | 2004-04-30 | 2010-09-21 | Allergan, Inc. | Hypotensive lipid-containing biodegradable intraocular implants and related methods |
JP4195895B2 (ja) * | 2006-04-04 | 2008-12-17 | 小林製薬株式会社 | 吐出装置を備えた容器に収容される経口投与用液体医薬製剤 |
US20080003280A1 (en) * | 2006-06-26 | 2008-01-03 | Levine Brian M | Combination cough treatment compounds and method of treating common coughs |
US20110008437A1 (en) | 2009-04-20 | 2011-01-13 | Altman Gregory H | Silk Fibroin Hydrogels and Uses Thereof |
GB201014391D0 (en) * | 2010-08-27 | 2010-10-13 | Biocopea Ltd | Drug composition and its use in therapy |
GB0919889D0 (en) * | 2009-11-13 | 2009-12-30 | Biocopea Ltd | Drug composition and its use in therapy |
GB201111485D0 (en) * | 2011-07-05 | 2011-08-17 | Biocopea Ltd | Drug composition and its use in therapy |
GB0921805D0 (en) * | 2009-12-14 | 2010-01-27 | Biocopea Ltd | Drug composition and its use in therapy |
GB0919893D0 (en) * | 2009-11-13 | 2009-12-30 | Biocopea Ltd | Drug composition and its use in therapy |
GB0921803D0 (en) * | 2009-12-14 | 2010-01-27 | Biocopea Ltd | Drug composition and its use in therapy |
UA47594U (uk) * | 2009-09-17 | 2010-02-10 | Игорь Викторович Трутаев | Комбінований засіб для лікування та профілактики захворювань дихальних шляхів |
JP5815226B2 (ja) * | 2009-11-30 | 2015-11-17 | 興和株式会社 | ロキソプロフェンを含有する医薬組成物 |
-
2011
- 2011-07-05 GB GBGB1111485.7A patent/GB201111485D0/en not_active Ceased
-
2012
- 2012-04-13 CN CN201280033545.1A patent/CN103648488A/zh active Pending
- 2012-04-13 EP EP17177202.3A patent/EP3251665A1/en not_active Withdrawn
- 2012-04-13 BR BR112014000159-6A patent/BR112014000159A2/pt not_active IP Right Cessation
- 2012-04-13 WO PCT/GB2012/050816 patent/WO2013004999A1/en active Application Filing
- 2012-04-13 AU AU2012280019A patent/AU2012280019B2/en not_active Ceased
- 2012-04-13 RU RU2016101054A patent/RU2016101054A/ru unknown
- 2012-04-13 MX MX2014000129A patent/MX2014000129A/es unknown
- 2012-04-13 CA CA2840793A patent/CA2840793A1/en not_active Abandoned
- 2012-04-13 KR KR1020147002930A patent/KR101676454B1/ko active IP Right Grant
- 2012-04-13 EP EP12716069.5A patent/EP2729136A1/en not_active Withdrawn
- 2012-04-13 JP JP2014517915A patent/JP2014518252A/ja active Pending
- 2012-04-13 RU RU2014103787/15A patent/RU2014103787A/ru unknown
-
2014
- 2014-01-06 ZA ZA2014/00010A patent/ZA201400010B/en unknown
-
2016
- 2016-11-09 AU AU2016256741A patent/AU2016256741A1/en not_active Abandoned
-
2017
- 2017-11-02 JP JP2017212821A patent/JP2018048189A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2012280019B2 (en) | 2016-10-27 |
RU2014103787A (ru) | 2015-08-20 |
CN103648488A (zh) | 2014-03-19 |
BR112014000159A2 (pt) | 2020-10-27 |
RU2016101054A (ru) | 2018-11-19 |
GB201111485D0 (en) | 2011-08-17 |
AU2012280019A1 (en) | 2014-01-23 |
AU2016256741A1 (en) | 2016-12-01 |
CA2840793A1 (en) | 2013-01-10 |
EP3251665A1 (en) | 2017-12-06 |
EP2729136A1 (en) | 2014-05-14 |
ZA201400010B (en) | 2015-04-29 |
WO2013004999A1 (en) | 2013-01-10 |
RU2016101054A3 (es) | 2018-11-19 |
KR101676454B1 (ko) | 2016-11-15 |
JP2014518252A (ja) | 2014-07-28 |
JP2018048189A (ja) | 2018-03-29 |
KR20140037947A (ko) | 2014-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2014000129A (es) | Combinaciones de farmacos y su usos en el tratamiento de una condicion de tos. | |
MX2013008851A (es) | Composiciones y metodos para el tratamiento de inflamacion cronica y enfermedades inflamatorias. | |
MX2020009780A (es) | Compuestos de inhibidor de autotaxina. | |
NZ702663A (en) | Nuclear transport modulators and uses thereof | |
IL231536A (en) | Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases | |
EP2739337A4 (en) | ARRANGEMENTS, SYSTEMS AND METHOD FOR INFUSING THERAPEUTICS IN THE BODY | |
MX345928B (es) | Composiciones terapeuticamente activas y metodos de uso de las mismas. | |
GB201106750D0 (en) | Novel compounds | |
IL254446A0 (en) | Implantable drug delivery preparations and treatment methods thereof | |
EP2582682A4 (en) | METHOD FOR THE TREATMENT OF LUNG DISEASES | |
EP2740729A4 (en) | QUINAZOLINE DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING THE COMPOUND, AND USE OF THE DERIVATIVE IN THE PREPARATION OF A MEDICAMENT | |
PH12016500863A1 (en) | Tetracyclic autotaxin inhibitors | |
GB2497453B8 (en) | Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV | |
PH12014500990A1 (en) | Methods for treating gout flares | |
PL2753182T3 (pl) | Środki czynne przeciw szczepom Pseudomonas powodującym choroby gnilne w uprawach grzybów, ich zastosowanie i zawierające je kompozycje | |
HK1200815A1 (en) | [1,2,4]triazolopyridines and their use as phospodiesterase inhibitors [124] | |
WO2012006585A3 (en) | Use of interleukin-15 to treat cardiovascular diseases | |
MX2013010947A (es) | Complejos de galio, composiciones farmacéuticas y métodos de uso. | |
TN2014000418A1 (en) | Methods for treating cancer using pi3k inhibitor and mek inhibitor | |
MX2013012551A (es) | Uso de sales de 3-carboxi-n-etil-n,n-dimetilpropan-1-aminio en el tratamiento de enfermedades cardiovasculares. | |
MX2013009456A (es) | Compuestos de azufre aromaticos sustituidos y metodos para su uso. | |
UA70710U (ru) | Способ профилактики рецидивов аллергодерматозов у больных с вторичными иммунодефицитными состояниями | |
UA65038U (ru) | Способ лечения больных послеродовыми психозами | |
UA60256U (ru) | Способ патогенетической профилактики и лечения внутрижелудочковых кровоизлияний (вжк) у новорожденных | |
TN2013000247A1 (en) | Compositions comprising a pi3k inhibitor and a mek inhibitor and their use for treating cancer |